RaySearch Laboratories AB (publ)
RSLBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $463 | $344 | $160 | $103 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $463 | $402 | $398 | $355 |
| Inventory | $11 | $9 | $14 | $30 |
| Other Curr. Assets | $49 | $89 | $83 | $72 |
| Total Curr. Assets | $985 | $802 | $628 | $516 |
| Property Plant & Equip (Net) | $527 | $590 | $649 | $667 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $548 | $530 | $519 | $523 |
| Long-Term Investments | $0 | $0 | $55 | $8 |
| Tax Assets | $4 | $6 | $26 | $29 |
| Other NC Assets | $28 | $24 | $0 | $10 |
| Total NC Assets | $1,106 | $1,150 | $1,248 | $1,228 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,091 | $1,953 | $1,876 | $1,745 |
| Liabilities | – | – | – | – |
| Payables | $39 | $42 | $24 | $49 |
| Short-Term Debt | $77 | $97 | $81 | $70 |
| Tax Payable | $42 | $5 | $5 | $4 |
| Deferred Revenue | $0 | $0 | $461 | $363 |
| Other Curr. Liab. | $546 | $530 | $43 | $57 |
| Total Curr. Liab. | $704 | $675 | $614 | $490 |
| LT Debt | $395 | $432 | $474 | $492 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $115 | $110 | $107 | $108 |
| Other NC Liab. | $1 | $1 | $24 | $0 |
| Total NC Liab. | $511 | $542 | $605 | $600 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $472 | $529 | $555 | $540 |
| Total Liabilities | $1,214 | $1,217 | $1,219 | $1,116 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $7 |
| Common Stock | $17 | $17 | $17 | $17 |
| Retained Earnings | $857 | $722 | $640 | $617 |
| AOCI | $1 | -$6 | -$2 | -$7 |
| Other Equity | $2 | $2 | $2 | -$5 |
| Total Equity | $877 | $735 | $657 | $628 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,091 | $1,953 | $1,876 | $1,745 |
| Net Debt | $9 | $186 | $395 | $460 |